CVS Overzicht aandelen
CVS Health Corporation biedt gezondheidsoplossingen in de Verenigde Staten.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 6/6 |
| Toekomstige groei | 1/6 |
| Prestaties in het verleden | 5/6 |
| Financiële gezondheid | 2/6 |
| Dividenden | 6/6 |
Beloningen
Risicoanalyse
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
US$103.00
FV
46.9% undervalued intrinsic discount18.02%
Revenue growth p.a.
1users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
6 days ago author updated this narrative
US$69.46
FV
21.3% undervalued intrinsic discount5.04%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
6 days ago author updated this narrative
US$62.09
FV
12.0% undervalued intrinsic discount7.00%
Revenue growth p.a.
1users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
20 days ago author updated this narrative
CVS Health Corporation Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | US$54.65 |
| 52 Week Hoogtepunt | US$83.25 |
| 52 Week Laag | US$52.77 |
| Bèta | 0.53 |
| 11 maand verandering | -15.39% |
| 3 maanden verandering | -6.33% |
| 1 Jaar Verandering | -23.11% |
| 33 jaar verandering | -41.71% |
| 5 jaar verandering | -23.81% |
| Verandering sinds IPO | 8,224.17% |
Recent nieuws en updates
CVS Health (NYSE:CVS) Has A Somewhat Strained Balance Sheet
Nov 03
CVS Health Stock Dip: Undervalued And Ready For A Turnaround
Oct 24Recent updates
CVS Health (NYSE:CVS) Has A Somewhat Strained Balance Sheet
Nov 03CVS Health Stock Dip: Undervalued And Ready For A Turnaround
Oct 24CVS Health: Glenview's Activism Ramps Up Pressure On Management
Sep 30CVS Health: At Least There's A Valuable Lesson (Rating Downgrade)
Sep 10A Piece Of The Puzzle Missing From CVS Health Corporation's (NYSE:CVS) Share Price
Aug 08CVS Health Q2 Earnings: CEO's Swinging Axe May Have Ended The Bear Run
Aug 07Here's Why CVS Health (NYSE:CVS) Has A Meaningful Debt Burden
Jul 21CVS Health: A Better Investment Than Walgreens Boots Alliance
Jul 09Vltava Fund - CVS Health Corp.: Why We Sold CVS
Jul 03CVS Health: Mismanagement, Eroding Moat And Poor Momentum Make It A Sell
Jun 21The Correct Play On CVS Health
Jun 06CVS Health: Downside Movement Is Overdramatic
May 26CVS Health: Secure Dividend And Upside Potential Presents Compelling Opportunity
May 15We Think Shareholders Are Less Likely To Approve A Pay Rise For CVS Health Corporation's (NYSE:CVS) CEO For Now
May 10CVS Health: A Terrible Earnings Report, But An Undervalued Stock
May 04CVS Health Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
May 03CVS Health: 8x P/E, 8% Growth Projection - It's A Market Blind Spot
Apr 22Sentiment Still Eluding CVS Health Corporation (NYSE:CVS)
Apr 14CVS Health: Lookback, Management Guidance Vs. Results 2018-To-Date
Apr 10Does CVS Health (NYSE:CVS) Have A Healthy Balance Sheet?
Mar 27CVS Health: Better Times Likely Ahead
Mar 12CVS Health: Lower Guidance But Risk/Reward Remains Attractive
Feb 15CVS Health FY23 Earnings: Downgrades Inevitable, Long Term Outlook In The Balance
Feb 07CVS Health: Back In The Buy Column
Jan 21CVS Health (NYSE:CVS) Has Announced That It Will Be Increasing Its Dividend To $0.665
Jan 17CVS Health: Shares Remain Modestly Undervalued, Robust Free Cash Flow, Technical Strength
Jan 08CVS Health (NYSE:CVS) Is Paying Out A Larger Dividend Than Last Year
Jan 03CVS Health: Risk/Reward Highly Skewed To The Upside
Dec 15Rendement voor aandeelhouders
| CVS | US Healthcare | US Markt | |
|---|---|---|---|
| 7D | -4.7% | -1.1% | -1.9% |
| 1Y | -23.1% | 0.7% | 30.4% |
Rendement versus industrie: CVS presteerde slechter dan de US Healthcare -sector, die het afgelopen jaar een rendement van 0.7 % opleverde.
Rendement versus markt: CVS presteerde slechter dan US Market, dat het afgelopen jaar een rendement van 30.4 % opleverde.
Prijsvolatiliteit
| CVS volatility | |
|---|---|
| CVS Average Weekly Movement | 4.0% |
| Healthcare Industry Average Movement | 6.7% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 15.0% |
| 10% least volatile stocks in US Market | 2.9% |
Stabiele aandelenkoers: CVS heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 4% ) van CVS is het afgelopen jaar stabiel geweest.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1996 | 259,500 | J. Joyner | www.cvshealth.com |
CVS Health Corporation biedt gezondheidsoplossingen in de Verenigde Staten. Het is actief via de segmenten Health Care Benefits, Health Services en Pharmacy & Consumer Wellness. Het Health Care Benefits segment biedt traditionele, vrijwillige en consumentgerichte zorgverzekeringsproducten en aanverwante diensten.
CVS Health Corporation Samenvatting
| CVS fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | US$70.21b |
| Inkomsten(TTM) | US$7.19b |
| Inkomsten(TTM) | US$361.86b |
9.6x
Koers/Winstverhouding0.2x
P/S-verhoudingIs CVS overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| CVS resultatenrekening (TTM) | |
|---|---|
| Inkomsten | US$361.86b |
| Kosten van inkomsten | US$309.85b |
| Brutowinst | US$52.00b |
| Overige uitgaven | US$44.81b |
| Inkomsten | US$7.19b |
Laatst gerapporteerde inkomsten
Jun 30, 2024
Volgende inkomensdatum
Nov 06, 2024
| Winst per aandeel (EPS) | 5.72 |
| Brutomarge | 14.37% |
| Nettowinstmarge | 1.99% |
| Schuld/Eigen Vermogen Verhouding | 86.5% |
Hoe presteerde CVS op de lange termijn?
Bekijk historische prestaties en vergelijking